Seattle-based RareCyte raises $20M for cell analysis products Seattle-based life sciences company RareCyte announced $20 million in new funding to advance its applications for the analysis of cells.
Seattle startup RareCyte raises $24M to advance new high-speed cell imaging platform Seattle-based startup RareCyte announced $24 million in new funding on Thursday to advance its applications for the analysis of cells.… Read More
Liquid biopsy startup RareCyte announces $30M round and new CEO to fuel rare cell detection A liquid biopsy sounds like far-future tech: It’s essentially a blood test that can detect cancer by analyzing DNA from… Read More
